(Q53975414)
Statements
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation. (English)
Antin JH
Lee SJ
Neuberg D
Alyea E
Soiffer RJ
Sonis S
Ferrara JL
1 March 2002
29
5
373-377
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference